Global Influenza Vaccine Market (2020-2025)

Global Influenza Vaccine Market (2020-2025)

Influenza Vaccine Market: Introduction

Flu is a contagious respiratory illness caused by influenza viruses that infect the nose, throat, and sometimes the lungs. It can cause mild to severe illness, and at times can lead to death. Fever, cough, sore throat, runny or stuffy nose, muscle or body aches, headaches, fatigue are the symptoms of the disease.

There are four types of influenza viruses: A, B, C and D. Human influenza A and B viruses cause seasonal epidemics of disease (known as the flu season) almost every winter in the United States. Influenza A viruses are the only influenza viruses known to cause flu pandemics, i.e., global epidemics of flu disease. A pandemic can occur when a new and very different influenza A virus emerges that both infects people and has the ability to spread efficiently between people. Influenza type C infections generally cause mild illness and are not thought to cause human flu epidemics. Influenza D viruses primarily affect cattle and are not known to infect or cause illness in people.

The best way to prevent flu is by getting a flu vaccine each year. The influenza vaccine is recommended by the World Health Organization (WHO) for high-risk groups, such as pregnant women, children, the elderly, health care workers, and people who have chronic illnesses. The United States Centers for Disease Control and Prevention (CDC) recommends the influenza vaccine for those aged six months or older who do not have contraindications. In healthy children over the age of two years, the vaccine reduces the chances of getting influenza by around two-thirds. In those with chronic obstructive pulmonary disease vaccination reduces exacerbations.

Market Dynamics

Drivers

High prevalence of influenza
Increase in government focus on immunization programs
Emerging vaccines
Technological progress in vaccine administration

Restraints

Longer timelines and implementation of stringent regulations
High costs associated with the development of vaccines

Opportunities

High growth prospects in emerging markets

Segments Covered

The Global Influenza Vaccine Market is segmented on the basis of Age Group, Vaccine Type, Administration Route and Distribution Channel.

Global Influenza Vaccine Market, By Age Group

Infant Vaccination
Adolescent Vaccination
Adult Vaccination

Global Influenza Vaccine Market, By Vaccine Type

Inactivated
Live Attenuated
Recombinant

Global Influenza Vaccine Market, By Administration Route

Intramuscular
Intranasal

Global Influenza Vaccine Market, By Distribution Channel

Hospital & Clinic
Medical Office
Retail Pharmacy
Urgent Care Unit

Company Profiles

The companies covered in this report are:

Abbott Biologicals B.V.
AstraZeneca
BioDiem
CSL
Daiichi-Sankyo
Emergent BioSolutions
Fluart Innovative Vaccines Kft.
Gamma Vaccines Pty Ltd.
GlaxoSmithKline plc
Innovio Pharmaceuticals
Merck & Co., Inc.
Mylan N.V.
Pfizer Inc.
Sanofi S.A.
Seqirus GmbH

Why to buy this report?

The report offers a comprehensive evaluation of the global Influenza vaccine market. The report includes the in-depth qualitative analysis, verifiable data from authentic sources and projections about market size. The projections are calculated using proven research methodologies.

The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys and observation of renowned personnel in the industry.

The report includes in-depth market analysis using Porter’s 5 force model. Impact of Covid-19 on the market is also featured in the report.

Report Highlights:

A complete analysis of the market including parent industry
Important market dynamics and trends
Market segmentation
Historical, current, and projected size of the market based on value and volume
Market shares and strategies of key players
Recommendations to companies for strengthening their foothold in the market